Top movers in Friday's after hours session
Bicara Therapeutics Inc BCAX
$27.10
▲ +3.16%
(+$0.83)
⬆️ Above Yest. High
🗓️ Earnings Next Week
Open
$26.62
Prev Close
$26.27
Day Range
$25.35 – $27.12
52W Range
$9.57 – $30.99
Market Cap
$1.78B
Beta
1.00
EPS (TTM)
$-2.77
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-09-13 |
| Shares Out. | 65,700,000 |
| Website | bicara.com/ ↗ |
| Phone | 16174684219 |
| Employees | 103 |
| Net Income | -$56.2M |
| Free Cash Flow | -$116.6M |
| Total Assets | $553.6M |
| Total Liabilities | $39.6M |
| Equity | $514.0M |
About Bicara Therapeutics Inc
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
Bicara Therapeutics Inc is a publicly traded company under the ticker symbol BCAX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-07-01)